Chunping Xu

710 total citations
22 papers, 518 citations indexed

About

Chunping Xu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Chunping Xu has authored 22 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Chunping Xu's work include Immune Cell Function and Interaction (4 papers), Genetic Neurodegenerative Diseases (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Chunping Xu is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Genetic Neurodegenerative Diseases (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Chunping Xu collaborates with scholars based in United States, China and Mexico. Chunping Xu's co-authors include Patrick H. Dussault, Joel Gottesfeld, Elisabetta Soragni, James R. Rusche, Heather L. Plasterer, David Herman, C. James Chou, Roman V. Shchepin, Lianxian Cui and Wei He and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Chunping Xu

22 papers receiving 513 citations

Peers

Chunping Xu
James K. Blodgett United States
C. Pichlo Germany
Inna Zilberleyb United States
Ariane E. Marolewski United States
James K. Blodgett United States
Chunping Xu
Citations per year, relative to Chunping Xu Chunping Xu (= 1×) peers James K. Blodgett

Countries citing papers authored by Chunping Xu

Since Specialization
Citations

This map shows the geographic impact of Chunping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunping Xu more than expected).

Fields of papers citing papers by Chunping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunping Xu. The network helps show where Chunping Xu may publish in the future.

Co-authorship network of co-authors of Chunping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunping Xu. A scholar is included among the top collaborators of Chunping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunping Xu. Chunping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henderson, Jordana M., Christoph Vo, Nona Abolhassani, et al.. (2025). CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA. Molecular Therapy — Nucleic Acids. 36(1). 102456–102456. 2 indexed citations
2.
Guo, Qi, Songfang Wu, Chunping Xu, Jinghan Wang, & Jianghua Chen. (2021). Global Disease Burden From Acute Glomerulonephritis 1990–2019. Kidney International Reports. 6(8). 2212–2217. 12 indexed citations
3.
Chen, Shaohua, Ying Shen, Hongbing Jiang, et al.. (2020). Impact of parathyroidectomy on left ventricular function in end stage renal disease patients. BMC Nephrology. 21(1). 479–479. 2 indexed citations
4.
Liu, Changnian, Chunping Xu, Pan Zhang, et al.. (2020). Abstract 4178: ETH-155008, a dual inhibitor of CDK and Pim in preclinical treatment of human B-cell lymphoma xenografts. Cancer Research. 80(16_Supplement). 4178–4178. 1 indexed citations
5.
Liu, Changnian, Bin Liu, Chunping Xu, et al.. (2019). ETH-155008, a Novel Selective Dual Inhibitor of FLT3 and CDK4/6 in Preclinical Treatment of Acute Myeloid Leukemia. Blood. 134(Supplement_1). 5141–5141. 4 indexed citations
6.
Zhang, Ping, Yi Yang, Hongbing Jiang, et al.. (2017). Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy. Renal Failure. 39(1). 736–744. 12 indexed citations
7.
Shan, Bing, Chunping Xu, Yaoyang Zhang, et al.. (2014). Quantitative Proteomic Analysis Identifies Targets and Pathways of a 2-Aminobenzamide HDAC Inhibitor in Friedreich’s Ataxia Patient iPSC-Derived Neural Stem Cells. Journal of Proteome Research. 13(11). 4558–4566. 23 indexed citations
8.
Soragni, Elisabetta, Chunping Xu, Heather L. Plasterer, et al.. (2012). Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia. Journal of Child Neurology. 27(9). 1164–1173. 27 indexed citations
9.
Soragni, Elisabetta, et al.. (2011). Evaluation of Histone Deacetylase Inhibitors as Therapeutics for Neurodegenerative Diseases. Methods in molecular biology. 793. 495–508. 25 indexed citations
10.
Xu, Chunping, Elisabetta Soragni, Vincent Jacques, James R. Rusche, & Joel Gottesfeld. (2011). Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route. Pharmaceuticals. 4(12). 1578–1590. 10 indexed citations
11.
Shchepin, Roman V., Chunping Xu, & Patrick H. Dussault. (2010). B(C6F5)3-Promoted Tandem Silylation and Intramolecular Hydrosilylation: Diastereoselective Synthesis of Oxasilinanes and Oxasilepanes. Organic Letters. 12(21). 4772–4775. 42 indexed citations
12.
Xu, Chunping, Elisabetta Soragni, C. James Chou, et al.. (2009). Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing. Chemistry & Biology. 16(9). 980–989. 102 indexed citations
13.
Xi, Xueyan, Hui Chen, Chunping Xu, et al.. (2009). Antigen Specificity of γδ T Cells Depends Primarily on the Flanking Sequences of CDR3δ. Journal of Biological Chemistry. 284(40). 27449–27455. 22 indexed citations
14.
Xu, Chunping, et al.. (2009). Asymmetric synthesis of 1,2-dioxanes: approaches to the peroxyplakoric acids. Tetrahedron. 65(47). 9680–9685. 16 indexed citations
15.
Chen, Hui, Zhun Wang, Huiyuan Zhang, et al.. (2008). Identification of Human T Cell Receptor γδ-recognized Epitopes/Proteins via CDR3δ Peptide-based Immunobiochemical Strategy. Journal of Biological Chemistry. 283(18). 12528–12537. 60 indexed citations
16.
Xu, Wei, et al.. (2007). [Expression of nuclear transcription factor kappaB in childhood acute lymphoblastic leukemia and its significance].. PubMed. 15(4). 767–71. 2 indexed citations
17.
Ma, Chi, et al.. (2006). The Intestinal Intraepithelial Lymphocytes with T Cell Receptor αβ Express Toll-Like Receptor 4 and Are Responsive to Lipopolysaccharide. International Archives of Allergy and Immunology. 141(4). 401–407. 5 indexed citations
18.
Xu, Chunping, Huiyuan Zhang, Hongbo Hu, et al.. (2006). γδ T cells recognize tumor cells via CDR3δ region. Molecular Immunology. 44(4). 302–310. 38 indexed citations
19.
Zaleta-Rivera, Kathia, Chunping Xu, Fengan Yu, et al.. (2006). A Bidomain Nonribosomal Peptide Synthetase Encoded by FUM14 Catalyzes the Formation of Tricarballylic Esters in the Biosynthesis of Fumonisins. Biochemistry. 45(8). 2561–2569. 63 indexed citations
20.
Xu, Chunping, et al.. (2005). Total Synthesis of Peroxyacarnoates A and D:  Metal-Mediated Couplings as a Convergent Approach to Polyunsaturated Peroxides. Organic Letters. 7(12). 2509–2511. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026